Peer-influenced content. Sources you trust. No registration required. This is HCN.
Listen to this podcast from Rafael Fonseca, MD, interim executive director, Mayo Clinic Comprehensive Cancer Center, who discusses specific measures the Mayo Clinic has taken for developing in-house testing.
Allergy & Immunology March 23rd 2020
The NCCN delivers guidance for cancer centers. Two guiding measures are key. First, ensure proactive, open channels of communication. Next, form an Incident Command Structure to respond rapidly to ever-changing info. Click to view other guidance.
Hematology March 23rd 2020
Patients with advanced cancer are at a much higher risk for bad outcomes with a coronavirus diagnosis. For oncologists, this means there can be absolutely no room for complacency. What can you do to be prepared?
The New England Journal of Medicine
Longer overall survival and similar safety profile were the endpoints in this NEJM piece, comparing those who received osimertinib with those who received a comparator EGFR-TKI.
Internal Medicine March 16th 2020
Can transfusion independence for multiple weeks be possible in patients with myelodysplastic syndromes? Read on to discover promising information you can share with your patients about reducing the severity of their anemia.
Hematology March 16th 2020
NEJM explores the question: Are we, in fact, what we eat? Can the periodic flipping of a “metabolic switch” truly help patients?
Allergy & Immunology March 16th 2020
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH